Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 12 Aug 2021

Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer

in Thoracic Oncology

Hao Zeng
Wei-wei Huang
Yu-jie Liu
Qin Huang
Sheng-min Zhao
Ya-lun Li
Pan-wen Tian
Wei-min Li

Frontiers in Oncology

doi 10.3389/fonc.2021.685047

4,507 views
10 citations

Original Research

Published on 10 Aug 2021

EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma

in Thoracic Oncology

Zhanyu Xu
Fanglu Qin
Liqiang Yuan
Jiangbo Wei
Yu Sun
Junqi Qin
Kun Deng
Tiaozhan Zheng
Shikang Li

Frontiers in Oncology

doi 10.3389/fonc.2021.691915

6,111 views
15 citations

Review

Published on 09 Aug 2021

Viral Infection and Lung Cancer Immunotherapy

in Thoracic Oncology

Ewa Kalinka
Izabela Chmielewska
Kamila Wojas-Krawczyk

Frontiers in Oncology

doi 10.3389/fonc.2021.577514

6,517 views
2 citations

Systematic Review

Published on 06 Aug 2021

Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020

in Thoracic Oncology

Zan Hou
Jiaqing Xie
Li Zhang
Gangyi Dai
Yuanhang Chen
Lang He

Frontiers in Oncology

doi 10.3389/fonc.2021.702216

9,760 views
28 citations

Review

Published on 06 Aug 2021

Tryptophan and Its Metabolites in Lung Cancer: Basic Functions and Clinical Significance

in Thoracic Oncology

Chenwei Li
Hui Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.707277

7,628 views
29 citations

Systematic Review

Published on 03 Aug 2021

Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Cheng-Qiong Wang
Xiao-Rong Huang
Min He
Xiao-Tian Zheng
Hong Jiang
Qian Chen
Teng-Yan Fan
Lin Zhan
Juan Ling
Ji-Hong Feng

Frontiers in Oncology

doi 10.3389/fonc.2021.649999

4,321 views
9 citations

Original Research

Published on 29 Jul 2021

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Qi Xiong
Boyu Qin
Lingli Xin
Bo Yang
Qi Song
Yu Wang
Sujie Zhang
Yi Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.659380

6,902 views
29 citations

Original Research

Published on 28 Jul 2021

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

in Thoracic Oncology

Qiang Wang
Danting Zhou
Fang Wu
Qingchun Liang
Qiongzhi He
Muyun Peng
Tianyu Yao
Yan Hu
Banglun Qian
Jingqun Tang

Frontiers in Oncology

doi 10.3389/fonc.2021.680287

6,348 views
24 citations

Review

Published on 27 Jul 2021

Carbon Nanotubes: A Summary of Beneficial and Dangerous Aspects of an Increasingly Popular Group of Nanomaterials

in Thoracic Oncology

Chengke Zhang
Licun Wu
Marc de Perrot
Xiaogang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.693814

37,839 views
84 citations

Original Research

Published on 26 Jul 2021

Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis

in Thoracic Oncology

Khader Shameer
Youyi Zhang
Dan Jackson
Kirsty Rhodes
Imran Khan A. Neelufer
Sreenath Nampally
Andrzej Prokop
Emmette Hutchison
Jiabu Ye
Vladislav A. Malkov

Frontiers in Oncology

doi 10.3389/fonc.2021.672916

13,528 views
26 citations

Original Research

Published on 26 Jul 2021

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials

in Thoracic Oncology

Hongyuan Zhu
Daipeng Xie
Yunfang Yu
Lintong Yao
Bin Xu
Luyu Huang
Shaowei Wu
Fasheng Li
Yating Zheng
Xinyi Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.659200

8,292 views
26 citations

Review

Published on 22 Jul 2021

Induction Strategy for Locally Advanced Thymoma

in Thoracic Oncology

Yang Zhang
Zongjuan Li
Yixing Chen
Lijie Tan
Zhaochong Zeng
Jianyong Ding
Shisuo Du

Frontiers in Oncology

doi 10.3389/fonc.2021.704220

8,061 views
16 citations

Original Research

Published on 22 Jul 2021

Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

in Thoracic Oncology

Guotao Yin
Ziyang Wang
Yingchao Song
Xiaofeng Li
Yiwen Chen
Lei Zhu
Qian Su
Dong Dai
Wengui Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.709137

5,463 views
40 citations

Original Research

Published on 22 Jul 2021

c-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma

in Thoracic Oncology

Weili Min
Chenyang He
Shuqun Zhang
Yang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.602900

4,698 views
4 citations

Systematic Review

Published on 21 Jul 2021

The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Haowei Wang
Fei Zhou
Meng Qiao
Xuefei Li
Chao Zhao
Lei Cheng
Xiaoxia Chen
Caicun Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.671874

6,467 views
34 citations

Original Research

Published on 21 Jul 2021

RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma

in Thoracic Oncology

Bing Liu
Yaqi Wang
Han Wang
Zhongwu Li
Lujing Yang
Shi Yan
Xin Yang
Yuanyuan Ma
Xuan Gao
Yanfang Guan

Frontiers in Oncology

doi 10.3389/fonc.2021.677826

8,327 views
19 citations

Original Research

Published on 21 Jul 2021

Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

in Thoracic Oncology

Sameh Daher
Yaacov R. Lawrence
Elizabeth Dudnik
Ekaterina Hanovich
Damien Urban
Nir Peled
Rossie Navon
Raya Leibowitz
Ariel Hammerman
Erez Battat

Frontiers in Oncology

doi 10.3389/fonc.2021.625668

6,338 views
11 citations

Original Research

Published on 21 Jul 2021

Optimal Cut-Off Values of the Positive Lymph Node Ratio and the Number of Removed Nodes for Patients Receiving Resection of Bronchopulmonary Carcinoids: A Propensity Score-Weighted Analysis of the SEER Database

in Thoracic Oncology

Qichen Chen
Mingxia Li
Pan Wang
Jinghua Chen
Hong Zhao
Jun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.696732

3,250 views
3 citations

Original Research

Published on 20 Jul 2021

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma

in Thoracic Oncology

Jikai Zhao
Ruiying Zhao
Chan Xiang
Jinchen Shao
Lianying Guo
Yuchen Han

Frontiers in Oncology

doi 10.3389/fonc.2021.692283

6,849 views
30 citations

Original Research

Published on 19 Jul 2021

Pulmonary Adenofibroma: Clinicopathological and Genetic Analysis of 7 Cases With Literature Review

in Thoracic Oncology

Zuoyu Liang
Ping Zhou
Yuxuan Wang
Ying Zhang
Dan Li
Xiaoxing Su
Yu Fan
Yuan Tang
Lili Jiang
Weiya Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.667111

7,814 views
7 citations

Original Research

Published on 19 Jul 2021

Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination

in Thoracic Oncology

Zhenfan Wang
Hao Li
Taorui Liu
Zewen Sun
Fan Yang
Guanchao Jiang

Frontiers in Oncology

doi 10.3389/fonc.2021.645486

4,409 views
8 citations

Original Research

Published on 16 Jul 2021

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma

in Thoracic Oncology

Zhendong Wang
Jun Zhu
Tianyi Wang
Hao Zhou
Jinjie Wang
Zhanghao Huang
Haijian Zhang
Jiahai Shi

Frontiers in Oncology

doi 10.3389/fonc.2021.639724

4,800 views
9 citations

Systematic Review

Published on 15 Jul 2021

Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Tianyu Lei
Jing Li
Hao Zhong
Huibo Zhang
Yan Jin
Jie Wu
Lan Li
Bin Xu
Qibin Song
Qinyong Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.680615

6,451 views
16 citations

Systematic Review

Published on 14 Jul 2021

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer

in Thoracic Oncology

Shuang Zhang
Shuang Li
Yanan Cui
Peiyan Zhao
Xiaodan Sun
Ying Cheng

Frontiers in Oncology

doi 10.3389/fonc.2021.696010

4,425 views
9 citations

1,969 articles

articles

Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer

EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma

Viral Infection and Lung Cancer Immunotherapy

Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020

Tryptophan and Its Metabolites in Lung Cancer: Basic Functions and Clinical Significance

Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

Carbon Nanotubes: A Summary of Beneficial and Dangerous Aspects of an Increasingly Popular Group of Nanomaterials

Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials

Induction Strategy for Locally Advanced Thymoma

Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

c-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma

The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma

Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

Optimal Cut-Off Values of the Positive Lymph Node Ratio and the Number of Removed Nodes for Patients Receiving Resection of Bronchopulmonary Carcinoids: A Propensity Score-Weighted Analysis of the SEER Database

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma

Pulmonary Adenofibroma: Clinicopathological and Genetic Analysis of 7 Cases With Literature Review

Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma

Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer